Ginsenosides: potential therapeutic agents against hepatic fibrosis
Zhengzheng Wu, Yi Liu · 2026
Read Ginsenosides: potential therapeutic agents against hepatic fibrosis by Zhengzheng Wu, Yi Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13324066.txt.
Description
Zhengzheng Wu and Yi Liu wrote a 2026 review of ginsenosides, the active compounds of ginseng, as candidate drugs against liver scarring. No drug yet treats hepatic fibrosis, where scar tissue slowly distorts the liver. The scarring is laid down by activated stellate cells, which respond to inflammation, injured liver cells, and gut microbe imbalance. The review sorts ginsenosides into three structural families and notes their good safety record.
Their power depends on fine structural details: the number and placement of their sugar parts and the shape at one key carbon. The compounds act on many fronts at once. They calm stellate cell activation, push those cells to die, protect liver cells, cool inflammation, and rebalance gut microbes. The authors frame the review as a theory base for clinical testing.
Catalog record
| CREATOR | Zhengzheng Wu, Yi Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |